Shares of Elanco Animal Health (NYSE: ELAN) are under pressure after the company's second-quarter earnings call. While results met previous expectations, a revised outlook for the bottom line in the second half upset investors enough to push the stock 14.2% lower as of 12:07 p.m. EDT on Monday.
Elanco Animal Health reported second-quarter earnings results that exceeded the quarterly guidance management provided in June. Around a year ago, Elanco splashed out on the $7.6 billion acquisition of Bayer Animal Health, and investors are looking for any signs of trouble.
Image source: Getty Images.
For further details see:
Why Elanco Animal Health Stock Is Falling Today